Wave Biotech, LLC will provide process and equipment expertise for Lentigen’s manufacturing platform based on proprietary lentiviral vector technology.
Wave’s key products include disposable contact materials and bioreactors that eliminate cleaning and validation, thus reducing costs in operations, according to Wave officials.